This invention relates in general to certain 5-substituted-6-oxo-[1,2]diazepanes of Formula I
as defined herein, which are protease inhibitors.
本发明一般涉及某些5-取代的6-氧代-[1,2]二氮杂烷,其化学式定义如下,它们是蛋白酶抑制剂。
PROTEASE INHIBITORS
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:EP1534292A2
公开(公告)日:2005-06-01
EP1534292A4
申请人:——
公开号:EP1534292A4
公开(公告)日:2008-04-02
[EN] PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE PROTEASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003099844A2
公开(公告)日:2003-12-04
This invention relates in general to certain 5-substituted-6-oxo-[1,2]diazepanes of Formula (I) as defined herein which are protease inhibitors.
Synthesis of cyclic hydrazines by ring-closing metathesis of dienes and enynes tethered by an N–N bond
作者:Jinsung Tae、Dong-Woo Hahn
DOI:10.1016/j.tetlet.2004.03.075
日期:2004.5
Ring-closing metathesis of dienes and enynes tethered by an N–N bond produced 6- to 10-membered cyclic 1,2-diaza compounds. The enyne RCM adducts were further transformed by Diels–Alder reaction into aromaticcompounds.